Immunic AG | Finanzwire

Basculer en Français

9476	Companies
185464	Keywords
117811	Articles
99314	Press releases

Home
Companies
Immunic AG

BRIEF

published on 06/02/2025 at 12:35, 6 months 3 days ago

Immunic to Attend Key Conferences in June

Biotechnology Conférences Immunic Vidofludimus Calcium Investor Meetings
PRESS RELEASE

published on 06/02/2025 at 12:30, 6 months 3 days ago

Immunic to Participate in Investor, Scientific and Industry Conferences in June
Immunic, Inc. to participate in multiple investor, scientific, and industry conferences in June 2025, presenting research and clinical pipeline updates

Biotechnology Conférences Scientific Research Immunic Inc. Clinical Pipeline
BRIEF

published on 05/02/2025 at 12:35, 7 months 3 days ago

Immunic to Engage in Key Conferences in May

Clinical Trials Conférences Multiple Sclerosis Immunic Celiac Disease
PRESS RELEASE

published on 05/02/2025 at 12:30, 7 months 3 days ago

Immunic to Participate in Scientific and Industry Conferences in May
Immunic to participate in scientific and industry conferences in May, including DDW and CMSC Annual Meeting 2025, presenting on IMU-856 and vidofludimus calcium for autoimmune diseases

Immunic Autoimmune Diseases Industry Conferences Scientific Conferences IMU-856
BRIEF

published on 04/30/2025 at 13:35, 7 months 5 days ago

Immunic Reports Phase 2 CALLIPER Trial Results for Vidofludimus Calcium

Multiple Sclerosis Vidofludimus Calcium Immunic AG Clinical Trial Results Phase 2 CALLIPER Trial
PRESS RELEASE

published on 04/30/2025 at 13:30, 7 months 5 days ago

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Immunic announces positive results from Phase 2 CALLIPER trial showing 30% reduced risk of disability worsening in Primary Progressive Multiple Sclerosis patients with vidofludimus calcium. Webcast scheduled for April 30

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 CALLIPER Trial
BRIEF

published on 04/10/2025 at 19:05, 7 months 24 days ago

Immunic Closes $5.1 Million Direct Offering Led by Aberdeen Investments

Biotechnology Chronic Diseases Direct Offering Aberdeen Investments Immunic Funding
PRESS RELEASE

published on 04/10/2025 at 19:00, 7 months 24 days ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. closes $5.1 million direct offering led by Aberdeen Investments to fund clinical trials and operations for autoimmune diseases. Issued via PRNewswire

Clinical Trials Immunic Inc. Autoimmune Diseases Direct Offering Aberdeen Investments
BRIEF

published on 04/09/2025 at 14:15, 7 months 25 days ago

Immunic, Inc. Announces $5.1 Million Direct Offering Guided by Aberdeen Investments

Biotechnology Nasdaq Investment Immunic, Inc. Direct Offering
PRESS RELEASE

published on 04/09/2025 at 14:10, 7 months 26 days ago

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations

Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments

Accesswire

Published on 12/05/2025 at 14:00, 12 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 12 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 37 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 42 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 12 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 27 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 12 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 12 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 7 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 12 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 27 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 12 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 27 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 28 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE